Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-30,641
Closed -$3.65M 596
2023
Q2
$3.65M Buy
+30,641
New +$3.17M 0.18% 140
2022
Q4
Sell
-418,275
Closed -$25.5M 1761
2022
Q3
$25.5M Buy
418,275
+135,128
+48% +$9.89M 0.9% 12
2022
Q2
$19.8M Sell
283,147
-343,425
-55% -$25.1M 0.59% 25
2022
Q1
$51.8M Buy
626,572
+578,615
+1,207% +$46.9M 1.96% 2
2021
Q4
$4.18M Sell
47,957
-536,074
-92% -$50.3M 0.16% 135
2021
Q3
$50.9M Buy
584,031
+374,740
+179% +$33.1M 1.86% 1
2021
Q2
$16.3M Sell
209,291
-540,973
-72% -$42.3M 0.37% 49
2021
Q1
$52.6M Sell
750,264
-196,636
-21% -$12.7M 1.64% 5
2020
Q4
$61.3M Buy
946,900
+531,500
+128% +$31.6M 2.03% 7
2020
Q3
$24.8M Buy
+415,400
New +$23.6M 3.28% 4

Other funds holding ORCL

Ergoteles's ORCL Position: Q3 2023 in Review

Ergoteles sold out of Oracle (ORCL) in Q3 2023, closing a stake of 30,641 shares — an estimated $3.65M sold.

Ergoteles first reported a position in ORCL in Q3 2020 and held it in 10 quarters. The position peaked at $61.3M in Q4 2020. 2,528 funds tracked by Wall St. Rank hold ORCL as of Q3 2023.

  • Ergoteles reported no remaining Oracle position as of Q3 2023 after selling out during the quarter.
  • Ergoteles sold 30,641 Oracle shares in Q3 2023, an estimated $3.65M.
  • Ergoteles first reported a position in Oracle in Q3 2020 and held it in 10 quarters.
  • Ergoteles's Oracle position peaked at $61.3M in Q4 2020.
  • 2,528 funds tracked by Wall St. Rank held Oracle as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.